Literature DB >> 29273106

Race and Alopecia Areata amongst US Women.

Jordan M Thompson1, Min Kyung Park1, Abrar A Qureshi2, Eunyoung Cho3.   

Abstract

Few studies have examined the clinical epidemiology of alopecia areata (AA) in regard to patient race, and therefore, any disparities in incidence or prevalence of disease are largely unexplored. We sought to investigate potential racial disparities amongst two large cohorts of women. We conducted a cross-sectional analysis from the Nurses' Health Study (NHS) and Nurses' Health Study II (NHSII), wherein participants self-reported a diagnosis of AA. We determined odds ratios for AA by race in a multivariate analysis. Among 63,960 women from NHS and 88,368 women from NHSII with information on race and diagnosis of AA, we identified 418 and 738 cases of AA, respectively. In NHS, the multivariate-adjusted odds ratio for AA was 2.72 (95% confidence interval 1.61-4.61) amongst black women as compared with white women. In NHSII, the multivariate-adjusted odds ratio was 5.48 (95% confidence interval 4.10-7.32) amongst black as compared with white women. In a secondary analysis designating participants by Hispanic ethnicity, in NHSII the multivariate odds ratio was 1.94 (95% CI 1.24-3.02) in Hispanic compared with non-Hispanic white women. In this study, we found increased odds of AA based on self-reported race in black and Hispanic women as compared with white women. Further studies are needed to explore the mechanism of this racial disparity related to AA.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29273106     DOI: 10.1016/j.jisp.2017.10.007

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  8 in total

Review 1.  Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race.

Authors:  Melissa H Roberts; Esther Erdei
Journal:  Autoimmun Rev       Date:  2019-11-14       Impact factor: 9.754

2.  A Prospective Six-month Single-blind Study Evaluating Changes in Hair Growth and Quality Using a Nutraceutical Supplement in Men and Women of Diverse Ethnicities.

Authors:  Thomas J Stephens; Sheryl Berkowitz; Tess Marshall; Sophia Kogan; Isabelle Raymond
Journal:  J Clin Aesthet Dermatol       Date:  2022-01

3.  Needs Assessment to Enhance Knowledge of People in Puerto Rico Living with Alopecia Areata.

Authors:  Rafael J Rivera-Ortiz; Edna Acosta-Pérez; Frances S Nieves-Casasnovas; Franchesca N Sánchez-Quintana
Journal:  P R Health Sci J       Date:  2021-09       Impact factor: 0.600

Review 4.  Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity.

Authors:  Mark R Cullen; Adina R Lemeshow; Leo J Russo; David M Barnes; Yaa Ababio; Aida Habtezion
Journal:  Healthcare (Basel)       Date:  2022-03-23

5.  Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort.

Authors:  Yuki M F Andersen; Lea Nymand; Amy M DeLozier; Russel Burge; Emily Edson-Heredia; Alexander Egeberg
Journal:  BMJ Open       Date:  2022-02-16       Impact factor: 2.692

6.  Short communication: Comments on hair disorders associated with dupilumab based on VigiBase.

Authors:  Sunny Park; So Hyang Park; Young Joo Byun; Soo An Choi
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

7.  Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study.

Authors:  Tugba Kevser Uzuncakmak; Burhan Engin; Server Serdaroglu; Yalcin Tuzun
Journal:  Skin Appendage Disord       Date:  2020-10-28

8.  The epidemiology of alopecia areata: a population-based cohort study in UK primary care.

Authors:  M Harries; A E Macbeth; S Holmes; W S Chiu; W R Gallardo; M Nijher; S de Lusignan; C Tziotzios; A G Messenger
Journal:  Br J Dermatol       Date:  2021-10-21       Impact factor: 11.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.